Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease

Journal of the American College of Cardiology

Volumn 59, Issue 20, 2012, Pages 1763-1770

  Barbato, Emanuele ^a   Bartunek, Jozef ^a   Mangiacapra, Fabio ^a   Sciarretta, Sebastiano ^b   Stanzione, Rosita ^b   Delrue, Leen ^a   Cotugno, Maria ^b   Marchitti, Simona ^b   Iaccarino, Guido ^c   Sirico, Giusy ^c   Di Castro, Sara ^b   Evangelista, Anna ^b   Lambrechts, Diether ^d,e   Sinnaeve, Peter ^f   De Bruyne, Bernard ^a   Van De Werf, Frans ^f   Janssens, Stefaan ^f   Fox, Keith A A ^g   Wijns, William ^a   Volpe, Massimo ^b,h   Rubattu, Speranza ^b,h   more..

^a CARDIOVASCULAR CENTER   (Belgium)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

atrial natriuretic peptide; coronary artery disease; rs5065 gene variant

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; ATRIAL NATRIURETIC PEPTIDE GENE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 84860739086     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.017     Document Type: Article

References (34)

1. S. Rubattu, S. Sciarretta, V. Valenti, R. Stanzione, M. Volpe Natriuretic peptides: an update on bioactivity, potential therapeutic use and implication in cardiovascular diseases Am J Hypertens 21 2008 733 741 (Pubitemid 351913612)
2. T.J. Wang, M.G. Larson, D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663 (Pubitemid 38364624)
3. S. Rubattu, A. Barbato, S. Marchitti Determinants of N-terminal pro atrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy J Hypertens 28 2010 1638 1645
4. S. Barbato, S. Sciarretta, S. Marchitti Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort Int J Cardiol 152 2011 245 246
5. M. Volpe, P. Francia, G. Tocci Prediction of long term survival in chronic heart failure by multiple biomarker assessment A 15-year prospective follow-up study Clin Cardiol 33 2010 700 707
6. A.M. Makikallio, T.H. Makikallio, J.T. Korpelainen Natriuretic peptides and mortality after stroke Stroke 36 2005 1016 1020 (Pubitemid 40629295)
7. S. Scarpino, S. Marchitti, R. Stanzione ROS-mediated differential effects of the human atrial natriuretic peptide T2238C genetic variant on endothelial cells in vitro J Hypertens 27 2009 1804 1813
8. S. Rubattu, R. Stanzione, E. Di Angelantonio Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans Stroke 35 2004 814 818 (Pubitemid 38419783)
9. M. Gruchala, D. Ciecwierz, B. Wasag Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease Am Heart J 145 2003 125 131 (Pubitemid 36034507)
10. A.I. Lynch, S.A. Claas, D.K. Arnett A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae Curr Hypertens Rep 11 2009 35 42
11. I. Zhang, L. Cheng, M. He, B. Hu, T. Wu ANP T2238C, C-664G gene polymorphism and coronary heart disease in Chinese population J Huazhong Univ Sci Technolog Med Sci 26 2006 528 530
12. G. Ferrante, M. Nakano, F. Prati High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study Circulation 122 2010 2505 2513
13. P.W. Serruys, H.M. García-García, P. Buszman Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque Circulation 118 2008 1172 1182
14. U. Schönbeck, N. Gerdes, N. Varo Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells Circulation 106 2002 2888 2893 (Pubitemid 35424737)
15. K. Thygesen, J.S. Alpert, H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
16. I. Buysschaert, K.F. Carruthers, D.R. Dunbar A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study Eur Heart J 31 2010 1132 1141
17. Guidelines Subcommittee World Health Organization-International Society of Hypertension guidelines for the management of hypertension J Hypertens 17 1999 151 183
18. Report of a WHO Study Group Diabetes mellitus World Health Organ Tech Rep Ser 727 1985 1 113
19. S. Rubattu, G. Bigatti, A. Evangelista Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension J Am Coll Cardiol 48 2006 499 505 (Pubitemid 44093966)
20. P. Holvoet, J. Van Cleemput, D. Collen, J. Vanhaecke Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease Arterioscler Thromb Vasc Biol 20 2000 698 702 (Pubitemid 30151683)
21. A.I. Lynch, E. Boerwinkle, B.R. Davis Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension JAMA 299 2008 296 307 (Pubitemid 351159366)
22. S.L. Hazen Myeloperoxidase and plaque vulnerability Arterioscler Thromb Vasc Biol 24 2004 1143 1146 (Pubitemid 38880000)
23. X. Fu, S.Y. Kassim, W.C. Parks, J.W. Heinecke Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7) A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Biol Chem 276 2001 41279 41287
24. F. Shabani, J. McNeil, L. Tippett The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCl) is suppressed by anti-rheumatic drugs Free Radic Res 28 1998 115 123 (Pubitemid 28288697)
25. M.L. Brennan, M.S. Penn, F. Van Lente Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604 (Pubitemid 37288567)
26. S. Baldus, C. Heeschen, T. Meinertz Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445 (Pubitemid 37176448)
27. M. Navab, G.M. Ananthramaiah, S.T. Reddy The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J Lipid Res 45 2004 993 1007 (Pubitemid 38679495)
28. C.H. Macphee, K.E. Moores, H.F. Boyd Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low density lipoprotein: use of a novel inhibitor Biochem J 338 1999 479 487
29. S. Tsimikas, E.S. Brilakis, E.R. Miller Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N Engl J Med 353 2005 46 57 (Pubitemid 41007806)
30. S. Ehara, M. Ueda, T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960 (Pubitemid 32322222)
31. S.G. Tsouli, D.N. Kiortsis, E.S. Lourida Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia J Lipid Res 47 2006 2208 2214 (Pubitemid 44936131)
32. T. Wu, W.C. Willett, N. Rifai, I. Shai, J.E. Manson, E.B. Rimm Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? J Am Coll Cardiol 48 2006 973 979 (Pubitemid 44292442)
33. E. Barbato, S. Rubattu, J. Bartunek Role of cardiac natriuretic peptides in human coronary atherosclerosis Atherosclerosis 206 2009 258 264
34. V. Estrada, M.J. Tellez, J. Moya, R. Fernandez-Durango, J. Egido, A.F. Fernandez Cruz High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke Am J Hypertens 7 1994 1085 1089